Characteristics of cases and controls
| Cases (n = 70) | Controls (n = 210) | p Value | |
|---|---|---|---|
| Results shown as absolute numbers (%) unless stated otherwise. | |||
| *Daily use during a minimal period of 3 consecutive months; †comprising heart failure, myocardial infarction, angina pectoris, cerebrovascular accident, transient ischaemic attack, and peripheral vascular disease. | |||
| Men/women | 59/11 | 177/33 | |
| Age (years), mean (SD) | 55.1 (13.5) | 55.2 (13.5) | |
| Diuretic use* | 14 (20) | 20 (10) | 0.020 |
| Hypertension | 15 (21) | 21 (10) | 0.013 |
| All cardiovascular morbidity† | 17 (24) | 22 (10) | 0.004 |
| Heart failure | 7 (10) | 2 (1) | 0.000 |
| Myocardial infarction | 8 (11) | 14 (7) | 0.200 |